SYRE is Spyre Therapeutics, Inc. Common Stock (Healthcare) — a non-dividend-paying stock. Trading at $88.98. Market cap: $7.69B. Capital Quality Rank: 53/100 — Above average.
Stock snapshot
| Price | $88.98 |
| Market cap | $7.69B |
| Sector | Healthcare |
| Exchange | XNAS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 53 / 100 · Above average |
| ROIC (TTM) | -6.0% |
| Shareholder buyback yield | -26.58% |
| Altman Z-score zone | Safe |
About SYRE
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
Related non-dividend companies
Other non-dividend stocks investors research alongside SYRE. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is SYRE's current stock price?
SYRE (Spyre Therapeutics, Inc. Common Stock) is currently trading at $88.98.
Does SYRE pay a dividend?
SYRE (Spyre Therapeutics, Inc. Common Stock) does not currently pay a regular dividend.
What is SYRE's Capital Quality Rank?
SYRE has a Capital Quality Rank of 53/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track SYRE in DiviDrip
Add SYRE to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search SYRE and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.